[HTML][HTML] ATTR epidemiology, genetics, and prognostic factors
CA Obi, WC Mostertz, JM Griffin… - Methodist DeBakey …, 2022 - ncbi.nlm.nih.gov
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed disease and an
underestimated cause of both heart failure and conduction abnormalities. It is characterized …
underestimated cause of both heart failure and conduction abnormalities. It is characterized …
Diagnosis and screening of patients with hereditary transthyretin amyloidosis (hATTR): current strategies and guidelines
MD Benson, NR Dasgupta, R Rao - Therapeutics and Clinical Risk …, 2020 - Taylor & Francis
The outlook for transthyretin amyloidosis (ATTR) is changing with the availability of new and
emerging treatments. ATTR now appears to be more common than previously thought and is …
emerging treatments. ATTR now appears to be more common than previously thought and is …
Diagnostic yield of advanced genetic testing in patients with hereditary neuropathies: A retrospective single‐site study
KJ Felice, CH Whitaker, S Khorasanizadeh - Muscle & Nerve, 2021 - Wiley Online Library
Abstract Introduction/Aims Advanced genetic testing including next‐generation sequencing
(AGT/NGS) has facilitated DNA testing in the clinical setting and greatly expanded new gene …
(AGT/NGS) has facilitated DNA testing in the clinical setting and greatly expanded new gene …
[HTML][HTML] Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations
D Russo, F Cappelli, G Di Bella, G Tini, A Porcari… - International Journal of …, 2023 - Elsevier
Backgorund Hereditary transthyretin (vATTR) cardiac amyloidosis has extremely different
features according to the type of transthyretin (TTR) mutation. Data about …
features according to the type of transthyretin (TTR) mutation. Data about …
Hereditary Transthyretin Amyloidosis: Impact of Classic and New Treatments on Kidney Function
E Meléndrez-Balcázar, K Aranda-Vela… - American Journal of …, 2024 - Elsevier
Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive, and life-threatening
disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal …
disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal …
Enlarged cross-sectional area in peripheral nerves in Swedish patients with hereditary V30M transthyretin amyloidosis
S Arvidsson, R Eriksson, I Anan, V Heldestad - Annals of Medicine, 2023 - Taylor & Francis
Introduction In hereditary transthyretin amyloidosis (ATTRv), two different fibrillar forms
causing the amyloid deposition, have been identified, displaying substantially cardiac or …
causing the amyloid deposition, have been identified, displaying substantially cardiac or …
Hereditary Transthyretin Amyloidosis and the Impact of Classic and New Treatments on Kidney Function: A Review
E Meléndrez-Balcázar, K Aranda-Vela… - American Journal of … - ajkd.org
Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive, and life-threatening
disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal …
disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal …
[PDF][PDF] Поражение периферической нервной системы при системном амилоидозе
ОЕ Зиновьева - 2022 - sechenov.ru
Системный амилоидоз объединяет группу заболеваний, характеризующуюся
внеклеточным диффузным отложением фибриллярного белка (амилоида), что ведет к …
внеклеточным диффузным отложением фибриллярного белка (амилоида), что ведет к …
Neuropatie sensitive
AL Kaminsky, JP Camdessanché - EMC-Neurologia, 2022 - Elsevier
Le neuropatie sensitive sono le più frequenti delle neuropatie. Le eziologie sono numerose
e si differenziano per il loro quadro clinico e neurofisiologico. Dal momento che la prognosi …
e si differenziano per il loro quadro clinico e neurofisiologico. Dal momento che la prognosi …